2025
Interstitial cervical needle-guide ring-cap prototype for patient-specific ring-and-tandem brachytherapy
Kuete L, Glennon A, Ptashnik S, Schickel M, Damast S, Tien C. Interstitial cervical needle-guide ring-cap prototype for patient-specific ring-and-tandem brachytherapy. Brachytherapy 2025 PMID: 40480925, DOI: 10.1016/j.brachy.2025.04.009.Peer-Reviewed Original Research
2024
Bladder Health Knowledge, Attitudes, and Beliefs among US Adolescent Women
Camenga D, Brady S, Bilger A, Klusaritz H, Lipman T, Levin E, Brown O, Cunningham S, LaCoursiere D, James A, Gahagan S, Hebert-Beirne J, Low L, Consortium P, Brubaker L, Mueller E, Acevedo-Alvarez M, Fitzgerald C, Hardacker C, Hebert-Beirne J, Griffith J, Kenton K, Simon M, Brown O, Geynisman-Tan J, Mueller M, Markland A, Vaughan C, Coyne-Beasley T, Burgio K, Lewis C, McGwin G, Williams B, Lukacz E, LaCoursiere D, Gahagan S, Nodora J, Low L, Miller J, Smith A, McGwin G, Rudser K, Brady S, Fok C, Harlow B, Scal P, Rockwood T, Newman D, Smith A, Berry A, Bilger A, Lipman T, Klusaritz H, Stapleton A, Wyman J, Sutcliffe S, James A, Lowder J, Meister M, Rickey L, Camenga D, Cunningham S, Brubaker L, Bethesda, Norton J. Bladder Health Knowledge, Attitudes, and Beliefs among US Adolescent Women. Journal Of Pediatric And Adolescent Gynecology 2024, 38: 60-67. PMID: 39374689, PMCID: PMC11769763, DOI: 10.1016/j.jpag.2024.09.008.Peer-Reviewed Original ResearchPrevention of Lower Urinary Tract SymptomsPrevent lower urinary tract symptomsLower urinary tract symptomsBladder healthUrinary tract symptomsFocus groupsData related to knowledgeWomen's overall healthQuality of lifeExposure to formal educationRelated to knowledgeHealthy behaviorsWomen's knowledgeEnvironmental barriersPreventive interventionsHealth knowledgeOverall healthInductive approachLife courseHealthBladder functionLack of informationAdolescent womenStigmaBladder
2023
Bladder-Induced Compression of the External Iliac Veins: Recognition and Implications for Treatment
Cornman-Homonoff J, Deshmukh A, Lozada J, Mojibian H. Bladder-Induced Compression of the External Iliac Veins: Recognition and Implications for Treatment. Vascular And Endovascular Surgery 2023, 58: 367-371. PMID: 37961845, DOI: 10.1177/15385744231216160.Peer-Reviewed Original ResearchUnnecessary stentingChronic bladder outlet obstructionBladder outlet obstructionExternal iliac veinClot migrationDVT formationPulmonary embolismOutlet obstructionIliac veinInappropriate treatmentBladder volumeSonographic imagingAdjacent veinsStentingVeinTreatmentEmbolismComplicationsBladderObstructionChanges in Autonomic Nervous System Activity in Children With Spina Bifida: A Case-Control Study
Kim B, Franco I, Lee Y, Han S, Kim S. Changes in Autonomic Nervous System Activity in Children With Spina Bifida: A Case-Control Study. International Neurourology Journal 2023, 27: 192-199. PMID: 37798886, PMCID: PMC10556434, DOI: 10.5213/inj.2346080.040.Peer-Reviewed Original ResearchHeart rate variability parametersControl groupSpina bifidaNN intervalsAutonomic nervous system dysfunctionAutonomic nervous system activityBladder filling phaseVideo-urodynamic studyNervous system dysfunctionCase-control studyNervous system activityR interval differencesLF/HF valuesVariability parametersSympathetic preponderanceNeurogenic bladderUrodynamic studiesSympathetic activityVesicoureteral refluxSystem dysfunctionParasympathetic activityPatientsSpina bifida groupBladderBifida
2022
Need for Public Health Messaging Related to Bladder Health from Adolescence to Advanced Age
Burgio K, Cunningham S, Newman D, Low L, Nodora J, Lipman T, Gahagan S, Klusaritz H, James A, Rickey L, Kenton K, Hebert-Beirne J, Williams B, Brubaker L, Acevedo-Alvarez M, M. Fitzgerald C, T. Hardacker C, Lavender M, Geynisman-Tan J, W. Griffith J, Simon M, D. Markland A, Coyne-Beasley T, E. Lewis C, McGwin G, P. Vaughan C, S. Lukacz E, Gahagan S, LaCoursiere D, M. Miller J, L. Harlow B, D. Rudser K, S. Brady S, Chu H, S. Fok C, Scal P, Rockwood T, L. Smith A, Berry A, Klusaritz H, E. Stapleton A, F. Wyman J, Sutcliffe S, S. James A, L. Lowder J, R. Meister M, A. Brault M, R. Camenga D, Brubaker L, Barthold J. Need for Public Health Messaging Related to Bladder Health from Adolescence to Advanced Age. Journal Of Women's Health 2022, 32: 224-238. PMID: 36454206, PMCID: PMC9940805, DOI: 10.1089/jwh.2022.0185.Peer-Reviewed Original ResearchConceptsBladder healthPublic health messagingAge groupsHealth messagingPriority audienceIndividual prevention strategiesPublic healthAdvanced agePrevention strategiesUniform desireRisk statusLife courseHealthFocus group dataAgeStudy of habitsAdult women's experiencesFocus groupsMore researchWomen's experiencesGroupGroup dataParticipantsBladderSymptomsPostprocedural Pain Associated With 5 Versus 20 Intradetrusor Injections of OnabotulinumtoxinA for Treatment of Overactive Bladder: A Multicenter Randomized Clinical Trial
Chang E, Ringel N, Woodburn K, Tanner J, Bassaly R, Greene K, Wyman A, Iglesia C. Postprocedural Pain Associated With 5 Versus 20 Intradetrusor Injections of OnabotulinumtoxinA for Treatment of Overactive Bladder: A Multicenter Randomized Clinical Trial. Obstetrical & Gynecological Survey 2022, 77: 650-651. DOI: 10.1097/ogx.0000000000001102.Peer-Reviewed Original ResearchOveractive bladderNonneurogenic overactive bladderThird-line therapyΒ-agonist therapyAmerican Urological AssociationFemale pelvic medicineSociety of UrodynamicsIntradetrusor injectionsPain AssociatedTreatment episodesClinical trialsUrological AssociationPelvic medicineBladderTherapyBehavioral changesInjectionWide variationMulticenterOnabotulinumtoxinACholinergicUrodynamicsTrialsMedical Therapy with Antimuscarinics and ß3-Agonists
Goodridge S, Rickey L. Medical Therapy with Antimuscarinics and ß3-Agonists. 2022, 147-164. DOI: 10.1007/978-3-030-84352-6_8.Peer-Reviewed Original ResearchOveractive bladderManagement of OABTreatment of OABMedical therapy optionsSecond-line therapyFirst-line treatmentSide effect profileBeta-3 agonistQuality of lifeMedical therapyEffect profileTherapy optionsDrug classesComparative efficacyBehavioral modificationAntimuscarinicsBladderTherapyEfficacyTreatmentPharmacotherapyPatientsAgonistsLarge subsetProgression
2021
Characteristics of Online Crowdfunding Campaigns for Urological Cancers in the United States
Holler J, Hakam N, Nabavizadeh B, Sadighian M, Shibley W, Li K, Weiser L, Rios N, Enriquez A, Leapman M, Amend G, Breyer B. Characteristics of Online Crowdfunding Campaigns for Urological Cancers in the United States. Urology Practice 2021, 9: 56-63. PMID: 37145560, DOI: 10.1097/upj.0000000000000275.Peer-Reviewed Original ResearchUrological cancersActive treatmentCancer campaignsMajor urological cancersPrimary cancer typeCross-sectional studyWilcoxon rank sum testRank sum testRecipient ageMultivariable analysisPatient populationTesticular malignancyMalignancy typeTesticular cancerKidney cancerMedical careCancerCancer typesMedical expensesFinancial burdenOutcomesBladderKruskal-WallisProstateAgeA Case of Pheochromocytoma as a Subsequent Neoplasm in a Survivor of Childhood Embryonal Rhabdomyosarcoma
Rodwin RL, Janardan SK, Hofstatter EW, Kadan-Lottick NS. A Case of Pheochromocytoma as a Subsequent Neoplasm in a Survivor of Childhood Embryonal Rhabdomyosarcoma. Journal Of Pediatric Hematology/Oncology 2021, 44: e585-e588. PMID: 35200227, PMCID: PMC8873988, DOI: 10.1097/mph.0000000000002270.Peer-Reviewed Case Reports and Technical NotesConceptsChildhood embryonal rhabdomyosarcomaSubsequent neoplasmsEmbryonal rhabdomyosarcomaGenetic testingPathogenic variantsCase of pheochromocytomaChildhood cancer survivorsCancer predispositionClinical presentationCancer survivorsGenetic cancer predispositionClinical implicationsUncertain significanceNeoplasmsRhabdomyosarcomaSurvivorsPredispositionPheochromocytomaBladderTestingDeafnessVariantsWomenPrenatal ultrasound findings of covered bladder exstrophy and persistent cloaca
Ozcan T, Woo L, Wien M, Lazebnik N. Prenatal ultrasound findings of covered bladder exstrophy and persistent cloaca. Journal Of Clinical Ultrasound 2021, 49: 834-837. PMID: 34235755, DOI: 10.1002/jcu.23036.Peer-Reviewed Original ResearchLearning from BISCAY: The future of biomarker-based trial design in bladder cancer
Meza L, Salgia N, Patel K, Pal S. Learning from BISCAY: The future of biomarker-based trial design in bladder cancer. Cancer Cell 2021, 39: 910-912. PMID: 34256907, DOI: 10.1016/j.ccell.2021.06.011.Commentaries, Editorials and Letters
2020
Ureteric Duplications and Ureterocoeles
Kisa P, Joseph V, Sloan K, Hittelman A. Ureteric Duplications and Ureterocoeles. 2020, 925-932. DOI: 10.1007/978-3-030-41724-6_90.Peer-Reviewed Original ResearchUrinary tract infectionEctopic ureteral insertionRenal functionSymptomatic patientsTract infectionsVesicoureteric refluxUreteric duplicationUreteral obstructionUrinary tractTreatment aimUreteral insertionPostmortem examinationCommon anomalyInfection rateInfectionIncontinenceHydronephrosisPatientsUreterBladderObstructionRefluxPathologyRepresent oneTractPosterior Urethral Valves
Wu C, Ntaganda E, Hittelman A, Wolke S, Amah C. Posterior Urethral Valves. 2020, 965-971. DOI: 10.1007/978-3-030-41724-6_93.Peer-Reviewed Original ResearchBenign and Malignant Diseases of the Prostate
Syed J, Sprenkle P. Benign and Malignant Diseases of the Prostate. 2020, 651-682. DOI: 10.1007/978-3-319-47771-8_79.Peer-Reviewed Original ResearchHuman adult and adolescent biodistribution and dosimetry of the synaptic vesicle glycoprotein 2A radioligand 11C-UCB-J
Bini J, Holden D, Fontaine K, Mulnix T, Lu Y, Matuskey D, Ropchan J, Nabulsi N, Huang Y, Carson RE. Human adult and adolescent biodistribution and dosimetry of the synaptic vesicle glycoprotein 2A radioligand 11C-UCB-J. EJNMMI Research 2020, 10: 83. PMID: 32666239, PMCID: PMC7359974, DOI: 10.1186/s13550-020-00670-w.Peer-Reviewed Original ResearchDose-limiting organUrinary bladderTime-activity curvesSynaptic densityOLINDA/EXM 1.0 softwareWhole-body PET scansWhole-body scanHuman adultsDose limitTotal radiation doseGastrointestinal tractPET scansHealthy adultsInjected activityRegion of interestLarge intestineNeuropsychiatric disordersEffective doseRelevant disordersBladderLiverRadiation doseAdultsMBqHigh uptakeA prototype open-ended multichannel intracavitary-interstitial hybrid applicator for gynecological high-dose-rate brachytherapy
Tien CJ, Chen Z. A prototype open-ended multichannel intracavitary-interstitial hybrid applicator for gynecological high-dose-rate brachytherapy. Radiological Physics And Technology 2020, 13: 187-194. PMID: 32424632, DOI: 10.1007/s12194-020-00567-2.Peer-Reviewed Original ResearchConceptsPrescription doseRate brachytherapyHybrid applicatorPrior patientsRisk doseMinimum doseOAR D2ccMultichannel applicatorCentral tandemDoseTarget coverageInterstitial needlesPatientsApplicator bodyBrachytherapyDistal endOpen distal endsPeripheral needlesPeripheral channelsSilico studiesNeedleBowelBladderD2ccRectum
2019
Benign and Malignant Diseases of the Prostate
Syed J, Sprenkle P. Benign and Malignant Diseases of the Prostate. 2019, 1-32. DOI: 10.1007/978-3-319-20317-1_79-1.Peer-Reviewed Original ResearchO1 Activity of the FGFR1–3 inhibitor infigratinib in patients with upper tract urothelial carcinoma and urothelial carcinoma of the bladder: Latest efficacy findings and comprehensive genomic profiling/cell-free DNA data
De Giorgi U, Pal S, Rosenberg J, Hoffman-Censits J, Quinn D, Petrylak D, Galsky M, Vaishampayan U, Gupta S, Burris H, Soifer H, Li G, Dambkowski C, Moran S, Ye Y, Daneshmand S, Delord J, Bajorin D. O1 Activity of the FGFR1–3 inhibitor infigratinib in patients with upper tract urothelial carcinoma and urothelial carcinoma of the bladder: Latest efficacy findings and comprehensive genomic profiling/cell-free DNA data. European Urology Open Science 2019, 18: e3405-e3406. DOI: 10.1016/s1569-9056(19)34582-8.Peer-Reviewed Original ResearchPD66-04 NATIONAL TRENDS AND PATHOLOGIC OUTCOMES OF NEOADJUVANT CHEMOTHERAPY AMONG PATIENTS WITH MICROPAPILLARY VARIANT UROTHELIAL CARCINOMA OF THE BLADDER
Javier-DesLoges* J, Abello A, Syed J, Sprenkle P, Hurwitz M, Kenney P, Leapman M. PD66-04 NATIONAL TRENDS AND PATHOLOGIC OUTCOMES OF NEOADJUVANT CHEMOTHERAPY AMONG PATIENTS WITH MICROPAPILLARY VARIANT UROTHELIAL CARCINOMA OF THE BLADDER. Journal Of Urology 2019, 201 DOI: 10.1097/01.ju.0000557466.16539.88.Peer-Reviewed Original Research227 Mix methods approach to determine patients’ perspectives on the acceptability of a urinary biomarker test in replacement of cystoscopy for bladder cancer surveillance
Tan W, Teo C, Chan D, Heinrich M, Feber A, Sarpong R, Allan J, Williams N, Brew-Graves C, Ng C, Kelly J. 227 Mix methods approach to determine patients’ perspectives on the acceptability of a urinary biomarker test in replacement of cystoscopy for bladder cancer surveillance. European Urology Open Science 2019, 18: e303. DOI: 10.1016/s1569-9056(19)30219-2.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply